Algorithms|Antineoplastic Agents|Biomarkers, Tumor|Carcinoma, Non-Small-Cell Lung|Cell Proliferation|Drug Evaluation, Preclinical|Drug Resistance, Neoplasm|Drug Synergism|Gene Expression Profiling|High-Throughput Screening Assays|Humans|Immunoblotting|Leukemia|Lung Neoplasms|Mutation|Protein Kinase Inhibitors|Receptor, Fibroblast Growth Factor, Type 1|TOR Serine-Threonine Kinases|Tumor Cells, Cultured